Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof
An oral composition comprising 3-[5-[4- (cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2- benzisoxazol-6-yl)methoxy]phenyl]propionic acid or a salt thereof and polyvinylpyrrolidone. The oral composition is useful as a pharmaceutical composition for oral application having the following properties (1) to (3): (1) no new-type facility is required for the production of the composition； (2) the composition can be produced by a simple process； and (3) the composition can be dissolved stably in the gastrointestinal tract even when the pH value in the gastrointestinal tract varies and therefore is improved in gastrointestinal adsorption.
